Effect of the Brugada syndrome mutation A39V on calmodulin regulation of Cav1.2 channels.

Mol Brain

Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Dr, NW, Calgary T2N 4N1, Canada.

Published: April 2014

AI Article Synopsis

  • The L-type calcium channel Cav1.2 is crucial for brain and heart function, and calmodulin (CaM) regulates its calcium-dependent gating through a process called calcium-dependent inactivation (CDI).
  • Mutant forms of CaM were used to study the activation of Cav1.2 channels, revealing that a specific mutation related to Brugada syndrome disrupts CDI while altering activation kinetics and voltage-dependence.
  • The findings suggest that mutations affecting CaM can change channel activation independently of calcium binding, highlighting the need for careful interpretation of CaM mutant effects on ion channel behavior.

Article Abstract

Background: The L-type calcium channel Cav1.2 is important for brain and heart function. The ubiquitous calcium sensing protein calmodulin (CaM) regulates calcium dependent gating of Cav1.2 channels by reducing calcium influx, a process known as calcium-dependent inactivation (CDI). Dissecting the calcium-dependence of CaM in this process has benefited greatly from the use of mutant CaM molecules which are unable to bind calcium to their low affinity (N-lobe) and high affinity (C-lobe) binding sites. Unlike CDI, it is unknown whether CaM can modulate the activation gating of Cav1.2 channels.

Results: We examined a Cav1.2 point mutant in the N-terminus region of the channel (A39V) that has been previously linked to Brugada syndrome. Using mutant CaM constructs in which the N- and/or C-lobe calcium binding sites were ablated, we were able to show that this Brugada syndrome mutation disrupts N-lobe CDI of the channel. In the course of these experiments, we discovered that all mutant CaM molecules were able to alter the kinetics of channel activation even in the absence of calcium for WT-Cav1.2, but not A39V-Cav1.2 channels. Moreover, CaM mutants differentially shifted the voltage-dependence of activation for WT and A39V-Cav1.2 channels to hyperpolarized potentials. Our data therefore suggest that structural changes in CaM that arise directly from site directed mutagenesis of calcium binding domains alter activation gating of Cav1.2 channels independently of their effects on calcium binding, and that the N-terminus of the channel contributes to this CaM dependent process.

Conclusions: Our data indicate that caution must be exercised when interpreting the effects of CaM mutants on ion channel gating.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012176PMC
http://dx.doi.org/10.1186/1756-6606-7-34DOI Listing

Publication Analysis

Top Keywords

brugada syndrome
12
cav12 channels
12
gating cav12
12
mutant cam
12
calcium binding
12
cam
10
calcium
9
syndrome mutation
8
cam molecules
8
binding sites
8

Similar Publications

Routine Electrical Substrate Mapping in Brugada Syndrome: Is Direct Epicardial Assessment Truly Necessary?

JACC Clin Electrophysiol

January 2025

Fondazione Toscana "Gabriele Monasterio," Pisa, Italy; Scuola Superiore Sant'Anna, Pisa, Italy. Electronic address:

View Article and Find Full Text PDF

Background: Superior caval vein obstruction is a rare complication of endocardial pacing lead implantation that can result in a right to left shunt.

Case Summary: A 3-year-old child with type 2 Brugada syndrome presented with mild cyanosis post-endocardial pacing implantation due to evolutionary right superior caval vein obstruction. This obstruction resulted in a right to left shunt across a previously unrecognized patent levo-atrial cardinal vein associated with partial anomalous pulmonary venous drainage.

View Article and Find Full Text PDF

Inappropriate Shocks in Brugada Syndrome Patients With a Subcutaneous Implantable Cardioverter Defibrillator.

Pacing Clin Electrophysiol

January 2025

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Background: This study aimed to compare inappropriate shock (IAS) rates between subcutaneous implantable cardioverter-defibrillator (S-ICD) and transvenous ICD (TV-ICD) in Brugada syndrome (BrS) patients and identify risk factors for IAS in S-ICD use.

Methods: We enrolled consecutive patients with BrS who underwent ICD implantation between 2013 and 2023. Data on clinical characteristics, S-ICD screening test data, and IAS occurrence were retrospectively analyzed.

View Article and Find Full Text PDF

Cardiac Implications in Dravet Syndrome: Can Electrocardiogram and Echocardiography Detect Hidden Risks?

Pediatr Neurol

January 2025

Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Pediatrics Research Group, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain; Pediatric Neurology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Background: Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy associated with loss-of-function variants in the SCN1A gene. Although predominantly expressed in the central nervous system, SCN1A is also expressed in the heart, suggesting a potential link between neuronal and cardiac channelopathies. Additionally, DS carries a high risk of sudden unexpected death in epilepsy (SUDEP).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!